Abstract
Glucose avidity, high glycolysis and l-lactate production, regardless of oxygen availability, are the main traits of cancer metabolic reprogramming. The idea that mitochondria are dysfunctional in cancer, thus causing a glycolysis increase for ATP production and l-lactate accumulation as a dead-end product of glucose catabolism, has oriented cancer research for many years. However, it was shown that mitochondrial metabolism is essential for cancer cell proliferation and tumorigenesis and that l-lactate is a fundamental energy substrate with tumor growth-promoting and signaling capabilities. Nevertheless, the known ability of mitochondria to take up and oxidize l-lactate has remained ignored by cancer research. Beginning with a brief overview of the metabolic changes occurring in cancer, we review the present knowledge of l-lactate formation, transport, and intracellular oxidation and underline the possible role of l-lactate metabolism as energetic, signaling and anabolic support for cancer cell proliferation. These unexplored aspects of cancer biochemistry might be exploited for therapeutic benefit.
Similar content being viewed by others
Abbreviations
- F2,6BP:
-
Fructose-2,6-bisphosphate
- GLN:
-
Glutamine
- GLU:
-
Glucose
- GLUT:
-
Glucose transporter
- G6P:
-
Glucose-6-phosphate
- HK:
-
Hexokinase
- l-LAC:
-
l-Lactate
- l-LDHA:
-
l-Lactate dehydrogenase A
- cl-LDH:
-
Cytosolic l-lactate dehydrogenase
- ml-LDH:
-
Mitochondrial l-lactate dehydrogenase
- MCT:
-
Monocarboxylate carrier
- MIM:
-
Mitochondrial inner membrane
- MOM:
-
Mitochondrial outer membrane
- MPC:
-
Mitochondrial pyruvate carrier
- mRC:
-
Mitochondrial respiratory chain
- OXPHOS:
-
Oxidative phosphorylation
- PDH:
-
Pyruvate dehydrogenase
- PDK:
-
Pyruvate dehydrogenase kinase
- PFK:
-
6-Phosphofructo-1-kinase
- PFKFB:
-
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase
- PK:
-
Pyruvate kinase
- PKM2:
-
Pyruvate kinase isoform M2
- PP pathway:
-
Pentose phosphate pathway
- PYR:
-
Pyruvate
- RLM:
-
Rat liver mitochondria
- ROS:
-
Reactive oxygen species
- VDAC:
-
Voltage-dependent anion channel
References
Griguer CE, Oliva CR (2011) Bioenergetics pathways and therapeutic resistance in gliomas: emerging role of mitochondria. Curr Pharm Des 17:2421–2427
Ippolito L, Marini A, Cavallini L et al (2016) Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget 7:61890–61904
Gogvadze V, Zhivotovsky B, Orrenius S (2010) The Warburg effect and mitochondrial stability in cancer cells. Mol Asp Med 31:60–74
Obre E, Rossignol R (2015) Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodelling, signaling and bioenergetic therapy. Int J Biochem Cell Biol 59:167–181
Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP (2017) Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol 14:11–31
Brooks GA (2016) Energy flux, lactate shuttling, mitochondrial dynamics, and hypoxia. Adv Exp Med Biol 903:439–455
Passarella S, de Bari L, Valenti D et al (2008) Mitochondria and l-lactate metabolism. FEBS Lett 582:3569–3576
San-Millán I, Brooks GA (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect. Carcinogenesis 38:119–133
Brand A, Singer K, Koehl GE et al (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24:657–671
de Bari L, Valenti D, Atlante A, Passarella S (2010) l-Lactate generates hydrogen peroxide in purified rat liver mitochondria due to the putative l-lactate oxidase localized in the intermembrane space. FEBS Lett 584:2285–2290
Guppy M, Leedman P, Zu X, Russell V (2002) Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364:309–315
Moreno-Sánchez R, Marín-Hernández A, Saavedra E et al (2014) Who controls the ATP supply in cancer cells? Biochemistry lessons to understand cancer energy metabolism. Int J Biochem Cell Biol 50:10–23
Viale A, Corti D, Draetta GF (2015) Tumors and mitochondrial respiration: a neglected connection. Cancer Res 75:3687–3691
Galina A (2014) Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity. Int J Biochem Cell Biol 54:266–271
Valenti D, Vacca RA, de Bari L (2015) 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. J Bioenerg Biomembr 47:493–506
Kee HJ, Cheong JH (2014) Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy. BMB Rep 47:158–166
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685–698
Jose C, Melser S, Benard G, Rossignol R (2013) Mitoplasticity: adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis. Antioxid Redox Signal 18:808–849
Wood IS, Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89:3–9
Airley R, Loncaster J, Davidson S et al (2001) Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis—free survival in advanced carcinoma of the cervix. Cancer Res 7:928–934
Szablewski L (2013) Expression of glucose transporters in cancers. Biochim Biophys Acta 1835:164–169
Zhao F, Ming J, Zhou Y, Fan L (2016) Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother Pharmacol 77:963–972
Liu Y, Cao Y, Zhang W et al (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11:1672–1682
Liu TQ, Fan J, Zhou L, Zheng S-S (2011) Effects of suppressing glucose transporter-1 by the antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int 10:72–77
Rastogi S, Banerjee S, Chellappan S, Simon GR (2007) Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. Cancer Lett 257:244–251
Martel F, Guedes M, Keating E (2016) Effect of polyphenols on glucose and lactate transport by breast cancer cells. Breast Cancer Res Treat 157:1–11
Gwak H, Haegeman G, Tsang BK, Song YS (2015) Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. Mol Carcinog 54:1529–1540
Mathupala SP, Ko YH, Pedersen PL (2006) Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25:4777–4786
Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol 19:17–24
Pedersen PL (2008) Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer. J Bioenerg Biomembr 40:123–126
Marín-Hernández A, Rodríguez-Enríquez S, Vital-González PA et al (2006) Determining and understanding the control of glycolysis in fast-growth tumor cells: flux control by an over-expressed but strongly product-inhibited hexokinase. FEBS J 273:1975–1988
Liu VM, Vander Heiden MG (2015) The role of pyruvate kinase M2 in cancer metabolism. Brain Pathol 25:781–783
Dong G, Mao Q, Xia W et al (2016) PKM2 and cancer: the function of PKM2 beyond glycolysis. Oncol Lett 11:1980–1986
Vander Heiden MG, Lunt SY, Dayton TL et al (2011) Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol 76:325–334
DeBerardinis RJ, Cheng T (2010) Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29:313–324
Locasale JW (2012) The consequences of enhanced cell-autonomous glucose metabolism. Trends Endocrinol Metab 23:545–551
Board M, Humm S, Newsholme EA (1990) Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 265:503–509
Mc Dermott EW, Barron ET, Smyth PP, O’Higgins NJ (1990) Premorphological metabolic changes in human breast carcinogenesis. Br J Surg 77:1179–1182
Zaccarin M, Bosello-Travain V, Di Paolo ML et al (2017) Redox status in a model of cancer stem cells. Arch Biochem Biophys 617:120–128
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516
Chandel NS (2014) Mitochondria as signaling organelles. BMC Biol 12:34
Arco AD, Satrùstegui J (2005) New mitochondrial carriers: an overview. Cell Mol Life Sci 62:2204–2227
Ozkaya AB, Ak H, Atay S, Aydin HH (2015) Targeting mitochondrial citrate transport in breast cancer cell lines. Anticancer Agents Med Chem 15:374–381
Senyilmaz D, Teleman AA (2015) Chicken or the egg: Warburg effect and mitochondrial dysfunction. F1000Prime Rep 7:41
DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350
Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G (2015) Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab 21:805–821
Galluzzi L, Kepp O, Kroemer G (2012) Mitochondria: master regulators of danger signalling. Nat Rev 13:780–788
Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931–947
Schumacker PT (2015) Reactive oxygen species in cancer: a dance with the devil. Cancer Cell 27:156–157
Sabharwal SS, Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat Rev Cancer 14:709–721
Okon IS, Zou MH (2015) Mitochondrial ROS and cancer drug resistance: implications for therapy. Pharmacol Res 100:170–174
Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313:459–465
Weinberg SE, Chandel NS (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11:9–15
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Adeva-Andany M, López-Ojén M, Funcasta-Calderón R et al (2014) Comprehensive review on lactate metabolism in human health. Mitochondrion 17:76–100
Proia P, Di Liegro CM, Schiera G, Fricano A, Di Liegro I (2016) Lactate as a metabolite and a regulator in the central nervous system. Int J Mol Sci 17:76–100
Schurr A (2006) Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 26:142–152
Quistorff B, Grunnet N (2011) The isoenzyme pattern of LDH does not play a physiological role; except perhaps during fast transitions in energy metabolism. Aging (Albany NY) 3:457–460
Compan V, Pierredon S, Vanderperre B et al (2015) Monitoring mitochondrial pyruvate carrier activity in real time using a BRET-based biosensor: investigation of the Warburg effect. Mol Cell 59:491–501
Hall MM, Rajasekaran S, Thomsen TW, Peterson AR (2016) Lactate: friend or foe. PM R 8:S8–S15
Kemppainen J, Fujimoto T, Kalliokoski KK et al (2002) Myocardial and skeletal muscle glucose uptake during exercise in humans. J Physiol 542:403–412
Chatham JC (2002) Lactate: the forgotten fuel! J Physiol 542:333
Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134:703–707
Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N et al (2011) Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 10:4047–4064
Sacktor B, Packerl L, Estabrookp R (1959) Respiratory activity in brain mitochondria. Arch Biochem Biophys 80:68–71
Cruz RS, de Aguiar RA, Turnes T et al (2012) Intracellular shuttle: the lactate aerobic metabolism. Sci World J 2012:420984. https://doi.org/10.1100/2012/420984
Blanco A, Zinkham WH (1963) Lactate dehydrogenases in human testes. Science 139:601–602
Goldberg E (1963) Lactic and malic dehydrogenases in human spermatozoa. Science 139:602–603
Swegen A, Curry BJ, Gibb Z et al (2015) Investigation of the stallion sperm proteome by mass spectrometry. Reproduction (Cambridge) 149:235–244
Laughlin MR, Taylor J, Chesnick AS, DeGroot M, Balaban RS (1993) Pyruvate and lactate metabolism in the in vivo dog heart. Am J Physiol 264:H2068–H2079
de Bari L, Atlante A, Valenti D, Passarella S (2004) Partial reconstruction of in vitro gluconeogenesis arising from mitochondrial l-lactate uptake/metabolism and oxaloacetate export via novel l-lactate translocators. Biochem J 380:231–242
Pizzuto R, Paventi G, Porcile C et al (2012) l-Lactate metabolism in HEP G2 cell mitochondria due to the l-lactate dehydrogenase determines the occurrence of the lactate/pyruvate shuttle and the appearance of oxaloacetate, malate and citrate outside mitochondria. Biochim Biophys Acta 1817:1679–1690
Lemire J, Mailloux RJ, Appanna VD (2008) Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS One 3:e1550. https://doi.org/10.1371/journal.pone.0001550
Chatham JC, Des Rosiers C, Forder JR (2001) Evidence of separate pathways for lactate uptake and release by the perfused rat heart. Am J Physiol Endocrinol Metab 281:E794–E802
Passarella S, Paventi G, Pizzuto R (2014) The mitochondrial l-lactate dehydrogenase affair. Front Neurosci 8:407
Kane DA (2014) Lactate oxidation at the mitochondria: a lactate–malate–aspartate shuttle at work. Front Neurosci 8:366
Halestrap AP (1975) The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J 148:85–96
Gallina FG, Gerez de Burgos NM, Burgos C, Coronel CE, Blanco A (1994) The lactate/pyruvate shuttle in spermatozoa: operation in vitro. Arch Biochem Biophys 308:515–519
Chiaretti B, Casciaro A, Minotti G, Eboli ML, Galeotti T (1979) Quantitative evaluation of the activity of the malate-aspartate shuttle in Ehrlich ascites tumor cells. Cancer Res 39:2195–2199
Chiarugi A, Dölle C, Felici R, Ziegler M (2012) The NAD metabolome—a key determinant of cancer cell biology. Nat Rev Cancer 12:741–752
Nikiforov A, Kulikova V, Ziegler M (2015) The human NAD metabolome: functions, metabolism and compartmentalization. Crit Rev Biochem Mol Biol 50:284–297
Zelenka J, Dvořák A, Alán L (2015) l-Lactate protects skin fibroblasts against aging-associated mitochondrial dysfunction via mitohormesis. Oxid Med Cell Longev 2015:351698
Rooney K, Trayhurn P (2011) Lactate and the GPR81 receptor in metabolic regulation: implications for adipose tissue function and fatty acid utilisation by muscle during exercise. Br J Nutr 106:1310–1316
Morland C, Lauritzen KH, Puchades M et al (2015) The lactate receptor, G-protein-coupled receptor 81/hydroxycarboxylic acid receptor 1: expression and action in brain. J Neurosci Res 93:1045–1055
Yang J, Ruchti E, Petit JM et al (2014) Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons. Proc Natl Acad Sci 111:12228–12233
Thomas AP, Halestrap AP (1981) The role of mitochondrial pyruvate transport in the stimulation by glucagon and phenylephrine of gluconeogenesis from l-lactate in isolated rat hepatocytes. Biochem J 198:551–560
Bonuccelli G, Tsirigos A, Whitaker-Menezes D et al (2010) Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9:3506–3514
Sonveaux P, Végran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Investig 118:3930–3942
de Bari L, Chieppa G, Marra E, Passarella S (2010) l-Lactate metabolism can occur in normal and cancer prostate cells via the novel mitochondrial l-lactate dehydrogenase. Int J Oncol 37:1607–1620
Chen YJ, Mahieu NG, Huang X et al (2016) Lactate metabolism is associated with mammalian mitochondria. Nat Chem Biol 12:937–943
Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47
Sellers K, Fox MP, Bousamra M et al (2015) Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Investig 125:687–698
Hensley CT, Faubert B, Yuan Q et al (2016) Metabolic heterogeneity in human lung tumors. Cell 164:681–694
Faubert B, Li KY, Cai L et al (2017) Lactate metabolism in human lung tumors. Cell 171:358–371
Hui S, Ghergurovich JM, Morscher RJ et al (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551:115–118
Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441–464
Pérez-Escuredo J, Dadhich RK, Dhup S et al (2016) Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15:72–83
Girgis H, Masui O, White NM et al (2014) Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer 13:101
Lee M, Yoon JH (2015) Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication. World J Biol Chem 6:148–161
Martinez-Outschoorn UE, Pavlides S, Howell A et al (2011) Stromal–epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 43:1045–1051
Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964
Ho PC, Bihuniak JD, Macintyre AN et al (2015) Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162:1217–1228
Chang CH, Qiu J, O’Sullivan D et al (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229–1241
Li F, Wang Y, Zeller KI, Potter JJ et al (2005) Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25:6225–6234
Lezi E, Swerdlow RH (2016) Lactate’s effect on human neuroblastoma cell bioenergetic fluxes. Biochem Pharmacol 99:88–100
Jose C, Bellance N, Rossignol R (2011) Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma? Biochim Biophys Acta 1807:552–561
Chen X, Qian Y, Wu S (2015) The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med 79:253–263
Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R (2009) HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9:1084–1101
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Bari, L., Atlante, A. Including the mitochondrial metabolism of l-lactate in cancer metabolic reprogramming. Cell. Mol. Life Sci. 75, 2763–2776 (2018). https://doi.org/10.1007/s00018-018-2831-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-018-2831-y